M. Barrachina

发表

Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models

I. Ferrer, M. Dierssen, M. Barrachina, 2005, Neurobiology of Disease.

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies

I. Ferrer, M. Barrachina, B. Puig, 2001, Journal of Neural Transmission.

Amyloid-β deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AβPP mRNA isoforms containing the Kunitz protease inhibitor

I. Ferrer, M. Barrachina, B. Puig, 2005, Neurochemistry International.

Adenosine A1 Receptor Protein Levels and Activity Is Increased in the Cerebral Cortex in Creutzfeldt-Jakob Disease and in Bovine Spongiform Encephalopathy-Infected Bovine-PrP Mice

I. Ferrer, M. Barrachina, J. Torres, 2006, Journal of neuropathology and experimental neurology.

CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat

M. Barrachina, J. Krupiński, I. Ferrer, 2002, Neuropharmacology.

Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease.

M. Barrachina, J. L. Rosa, E. Dalfo, 2004, Neurobiology of disease.

LPS upregulates MHC class II I-A expression in B lymphocytes at transcriptional and at translational levels.

M. Barrachina, A. Celada, E. Goñalons, 1999, Tissue antigens.

Translational control of MHC class II I-A molecules by IFN-gamma.

M. Barrachina, A. Celada, J. A. Garcia-Sanz, 1998, Journal of immunology.

Translational control of MHC class II I-A molecules by IFN-gamma.

M. Barrachina, A. Celada, J. A. Garcia-Sanz, 1998, Journal of immunology.

Induction of C/EBPβ and GADD153 expression by dopamine in human neuroblastoma cells Relationship with α-synuclein increase and cell damage

M. Barrachina, E. Dalfo, I. Ferrer, 2005, Brain Research Bulletin.

From transcription to cell surface expression, the induction of MHC class II I-Aα by interferon-γ in macrophages is regulated at different levels

M. Barrachina, A. Celada, J. Lloberas, 2001, Immunogenetics.

From transcription to cell surface expression, the induction of MHC class II I-A alpha by interferon-gamma in macrophages is regulated at different levels.

M. Barrachina, A. Celada, J. Lloberas, 2001, Immunogenetics.

Citicoline increases glutathione redox ratio and reduces caspase-3 activation and cell death in staurosporine-treated SH-SY5Y human neuroblastoma cells

I. Ferrer, M. Barrachina, S. Ambrosio, 2002, Brain Research.

Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy.

M. Barrachina, I. Ferrer, S. Juvés, 2007, The American journal of pathology.

Histone tail acetylation in brain occurs in an unpredictable fashion after death

M. Barrachina, I. Ferrer, S. Juvés, 2012, Cell and Tissue Banking.

Clomiphene citrate and liver-cell adenoma.

M. Barrachina, M. Prieto, D. Carrasco, 1984, The New England journal of medicine.

Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington’s Disease

M. Barrachina, I. Ferrer, E. Pérez-Navarro, 2013, NeuroMolecular Medicine.

Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease.

M. Barrachina, I. Ferrer, J. L. Mosquera, 2016, The American journal of pathology.

Modulation of Signal Transduction Pathways in Senescence-Accelerated Mice P8 Strain: A Useful Tool for Alzheimer’s Disease Research

M. Barrachina, I. Ferrer, J. L. Albasanz, 2011 .

Modulation of Signal Transduction Pathways in Senescence-Accelerated Mice P8 Strain: A Useful Tool for Alzheimer’s Disease Research

M. Barrachina, I. Ferrer, J. L. Albasanz, 2011 .

Dopamine induces autophagic cell death and α‐synuclein increase in human neuroblastoma SH‐SY5Y cells

M. Barrachina, A. Santidrián, I. Ferrer, 2003, Journal of neuroscience research.

Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies

M. Barrachina, I. Ferrer, S. Boluda, 2008, Cell and Tissue Banking.

Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease

Marís S. Sánchez, M. Boada, M. Barrachina, 2007, Brain Research.

BDNF genetic variants and methylation: effects on cognition in major depressive disorder

C. Soriano-Mas, Á. Carracedo, J. Costas, 2019, Translational Psychiatry.

Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b

M. Barrachina, I. Ferrer, S. Porta, 2014, Neurobiology of Disease.

DNA methylation regulates adenosine A2A receptor cell surface expression levels

M. Barrachina, I. Ferrer, J. L. Albasanz, 2010, Journal of neurochemistry.

Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies

I. Ferrer, M. Barrachina, C. Buesa, 2006, Neurobiology of Disease.

Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.

M. Barrachina, E. Dalfo, I. Ferrer, 2005, Brain research bulletin.

DNA methylation and Yin Yang‐1 repress adenosine A2A receptor levels in human brain

M. Barrachina, I. Ferrer, J. L. Albasanz, 2010, Journal of neurochemistry.

The locus control region of the MHC class II promoter acts as a repressor element, the activity of which is inhibited by CIITA.

M. Barrachina, A. Celada, J. Lloberas, 2010, Molecular immunology.

This information is current as Macrophages Is Cell Cycle Dependent The Expression of MHC Class II Genes in and

M. Barrachina, M. Comalada, J. Xaus, 2000 .

The Expression of MHC Class II Genes in Macrophages Is Cell Cycle Dependent1

M. Barrachina, M. Comalada, J. Xaus, 2000, The Journal of Immunology.

DNA Methylation of Alzheimer Disease and Tauopathy-Related Genes in Postmortem Brain

M. Barrachina, I. Ferrer, 2009, Journal of neuropathology and experimental neurology.

TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue

I. Ferrer, M. Barrachina, E. Castaño, 2006, Neurochemistry International.

MPP+ increases α-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells

M. Barrachina, I. Ferrer, F. Viñals, 2002, Brain Research.

Lipopolysaccharide Up-Regulates MHC Class II Expression on Dendritic Cells through an AP-1 Enhancer without Affecting the Levels of CIITA1

M. Barrachina, A. Celada, J. Lloberas, 2007, The Journal of Immunology.

CIITA AP-1 Enhancer without Affecting the Levels II Expression on Dendritic Cells through an Lipopolysaccharide UpRegulates MHC Class Lloberas and Antonio Celada

M. Barrachina, C. Casals, Maria Serra, 2007 .

Abnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease

M. Barrachina, J. L. Rosa, E. Dalfo, 2004, Neurobiology of Disease.

Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease

M. Barrachina, E. Dalfo, I. Ferrer, 2007, Neuroscience Letters.

Chapter 5 – Gene Regulation of Adenosine A2A Receptors in the Central Nervous System

M. Barrachina, Y. Chern, Chien-Yu Lin, 2017 .

Lysosome‐associated membrane protein 1 (LAMP‐1) in Alzheimer’s disease

M. Barrachina, C. Buesa, I. Ferrer, 2006, Neuropathology and applied neurobiology.

Phosphorylated Protein Kinases Associated with Neuronal and Glial Tau Deposits in Argyrophilic Grain Disease

I. Ferrer, M. Barrachina, B. Puig, 2003, Brain pathology.

Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains

M. Barrachina, B. Puig, I. Ferrer, 2002, Acta Neuropathologica.

Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells

I. Ferrer, M. Barrachina, S. Ambrosio, 2003, Journal of the Neurological Sciences.

Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

I. Ferrer, M. Barrachina, B. Puig, 2002, Acta Neuropathologica.

MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells.

M. Barrachina, I. Ferrer, F. Viñals, 2002, Brain research.

Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice.

T. Gómez-Isla, M. Barrachina, J. L. Rosa, 2004, Journal of neuropathology and experimental neurology.

Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the “adenosine hypothesis”

M. Barrachina, I. Ferrer, J. Sévigny, 2013, Purinergic Signalling.

Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease

I. Ferrer, M. Barrachina, J. L. Albasanz, 2007, Neuroscience Letters.

RESEARCH ARTICLE: Up‐regulation of Adenosine Receptors in the Frontal Cortex in Alzheimer's Disease

Isidro Ferrer, I. Ferrer, M. Barrachina, 2008, Brain pathology.

Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice

M. Barrachina, I. Ferrer, J. Torres, 2006, Neuroscience Letters.

Striatal adenosine A2A receptor expression is controlled by S-adenosyl-L-methionine-mediated methylation

F. Ciruela, M. Barrachina, I. Ferrer, 2014, Purinergic Signalling.

Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.

M. Barrachina, I. Ferrer, J. L. Albasanz, 2014, Journal of psychiatric research.

FKBP5 polymorphisms and hypothalamic-pituitary-adrenal axis negative feedback in major depression and obsessive-compulsive disorder.

C. Soriano-Mas, Á. Carracedo, J. Costas, 2018, Journal of psychiatric research.

Epigenetic Modulation of Adenosine A2A Receptor: A Putative Therapeutical Tool for the Treatment of Parkinson’s Disease

F. Ciruela, M. Barrachina, I. Ferrer, 2011 .

The role of DNA methylation of BDNF gene on clinical severity and cognitive performance in obsessive-compulsive disorder

C. Soriano-Mas, P. Alonso, J. Menchón, 2019, European Neuropsychopharmacology.